Webinars
On-Demand Webinars:

ACCC webinars provide the convenience of live and on-demand online learning from an esteemed group of presenters. Q&A discussions enable knowledge sharing and the exchange of ideas.

Virtual webinar – ReachMD video EMERALD trial MED-05221 12/2024
Learn about clinical trial data, including a post-hoc subgroup analysis of patients with ER-positive/HER2-negative ESR1-mutated metastatic breast cancer following progression on ET+CDK4/6i.
Speaker: Joyce O’Shaughnessy, MD
Texas Oncology
Baylor Charles A. Sammons Cancer Center
Dallas, TX
Host: ReachMD
Funding & support provided by Stemline Therapeutics, Inc., a Menarini Group Company

Managing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) as a Targeted Treatment Option
Learn more about a real-world study with tagraxofusp in patients with front-line and relapsed-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated as part of the European Named Patient Program (NPP)
Speaker: James Foran, MD | Professor of Medicine, Mayo Clinic College of Medicine & Science, Jacksonville, FL
Host: ReachMD
Funding & support provided by Stemline Therapeutics, Inc., a Menarini Group Company
FLASCO Webinars:

FLASCO provides webinars on our YouTube channel for reference at any time!